I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Dror Bacher Biography and Net Worth

COO of DarioHealth

Dror Bacher serves as Chief Operating Officer of the Company. Mr. Bacher previously served as our Vice President of Research and Development as well as Vice President of Operations since 2013 where he worked on product development as well as building a scalable supply chain. Mr. Bacher has over 18 years of experience in various technological companies and his expertise includes product management, product development and business operations in multi disciplinary environments. Between 2008 and 2013, Mr. Bacher Served in several leadership roles at Amdocs Limited (Nasdaq:DOX), including working as a part of the Chief Technology Office, managing enterprise development programs for a variety of software products associated with service delivery, as well as serving as head of process Prior to Amdocs, Mr. Bacher served in a senior role at Tower Semiconductor (Nasdaq:TSEM), the global specialty foundry leader for IC manufacturing, where he was responsible for business operations and commercialization expansion. Mr. Bacher holds a B.Sc. in computer science and an MBA degree from Haifa University.

What is Dror Bacher's net worth?: The estimated net worth of Dror Bacher is at least $157,367.65 as of July 2nd, 2021. Mr. Bacher owns 186,278 shares of DarioHealth stock worth more than $157,368 as of November 22nd. This net worth approximation does not reflect any other assets that Mr. Bacher may own. Learn More about Dror Bacher's net worth.
How do I contact Dror Bacher?: The corporate mailing address for Mr. Bacher and other DarioHealth executives is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. DarioHealth can also be reached via phone at (833) 914-3796 and via email at [email protected]. Learn More on Dror Bacher's contact information.
Has Dror Bacher been buying or selling shares of DarioHealth?: Dror Bacher has not been actively trading shares of DarioHealth during the past quarter. Most recently, Dror Bacher sold 804 shares of the business's stock in a transaction on Monday, November 8th. The shares were sold at an average price of $19.09, for a transaction totalling $15,348.36. Learn More on Dror Bacher's trading history.
Who are DarioHealth's active insiders?: DarioHealth's insider roster includes Dror Bacher (COO), Oded Cohen (Insider), Dennis McGrath (Director), and Erez Raphael (CEO). Learn More on DarioHealth's active insiders.
Are insiders buying or selling shares of DarioHealth?: In the last year, DarioHealth insiders bought shares 4 times. They purchased a total of 20,000 shares worth more than $16,500.00. The most recent insider tranaction occured on September, 11th when insider Steven Charles Nelson bought 5,000 shares worth more than $4,000.00. Insiders at DarioHealth own 16.5% of the company. Learn More about insider trades at DarioHealth.
Information on this page was last updated on 9/11/2024.

Dror Bacher Insider Trading History at DarioHealth

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2021	Sell	804	$19.09	$15,348.36
11/4/2021	Sell	200	$19.08	$3,816.00
11/2/2021	Sell	4,363	$19.07	$83,202.41
7/6/2021	Sell	2,479	$20.32	$50,373.28
7/2/2021	Sell	11,021	$20.63	$227,363.23	186,278

Dror Bacher Buying and Selling Activity at DarioHealth

DarioHealth Company Overview

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Today's Range

Now: $0.84

$0.80

$0.92

50 Day Range

MA: $0.95

$0.77

$1.13

2 Week Range

Now: $0.84

$0.71

$2.60

Volume

162,055 shs

Average Volume

110,404 shs

Market Capitalization

$28.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.51

I was wrong. Dead wrong.

From Porter & Company | Ad